Abstract:Membrane‐active enzymes are responsible for triggering biological pathways in the intra‐/extracellular matrix. Membrane‐active artificial organelles in protocells follow the same rules (e.g., concentration‐ and time‐dependent parameters, viscosity, and diffusion) as their natural counterparts to regulate the characteristics of the artificial intracellular environment and protocell's morphology. The intricate nature of eukaryotic cells with intracellular compartments having differences in component concentration and viscosity in their lumen provides (membrane‐active) enzymes to trigger time‐ and concentration‐dependent processes in the intra‐/extracellular matrix. Herein, membrane‐active, enzyme‐loaded artificial organelles (AOs) are capitalized upon to develop fluidic and stable proteinaceous membrane‐based protocells. AOs in protocells induce the self‐assembly of oligopeptides into an artificial cytoskeleton that underlines their influence on the structure and functionality of protocells. A series of microscopical tools is used to validate the intracellular assembly and distribution of cytoskeleton, the changing protocells morphology, and AOs inclusion within cytoskeletal growth. Thus, the dynamics, diffusion, and viscosity of intracellular components in the presence of cytoskeleton are evaluated by fluorescence tools and enzymatic assay. Membrane‐active alkaline phosphatase in polymersomes as AOs fulfills the requirements of biomimetic eukaryotic cells to trigger intracellular environment, mobility, viscosity, diffusion, and enzymatic activity itself as well as high mechanical stability and high membrane fluidity of protocells. Thus membrane‐active AOs in protocells provide a variable reaction space in a changing intracellular environment and underline their regulatory role in the fabrication of complex protocell architectures and functions. This study contributes significantly to the effective biomimetics of cell‐like structures, shapes, and functions.

Artificial Cells for Cellular Behavior Mimicry Induced by Sphingomyelin Degradation

Biomimetic Materials to Fabricate Artificial Cells

Artificial Cells: Past, Present and Future.

Reversible Deformation of Artificial Cell Colony Triggered by Actin Polymerization for Muscle Behavior Mimicry

Using ASMase knockout mice to model human diseases.

Biomimetic Protocells Featuring Macrophage-Like Capture and Digestion of Protein Pathogens

Synthetic control of actin polymerization and symmetry breaking in active protocells

Development of Artificial Cell Models Using Microfluidic Technology and Synthetic Biology

Molecular Basis for the Catalytic Mechanism of Human Neutral Sphingomyelinases 1 (Hsmpd2).

Protocells Capable of Generating a Cytoskeleton‐Like Structure from Intracellular Membrane‐Active Artificial Organelles

Molecular Modeling of the Three-Dimensional Structure of Human Sphingomyelin Synthase

Cellular Modulation by the Mechanical Cues from Biomaterials for Tissue Engineering.

Mimicomes: Mimicking Multienzyme System by Artificial Design

Artificial Compartments Encapsulating Enzymatic Reactions: Towards the Construction of Artificial Organelles

Encoding biological recognition in a bicomponent cell-membrane mimic

Cryo-EM Structure of Human Sphingomyelin Synthase and Its Mechanistic Implications for Sphingomyelin Synthesis

Synthesis of lipid membranes for artificial cells

Sphingomyelin Biosynthesis: Its Impact on Lipid Metabolism and Atherosclerosis

Versatile Phospholipid Assemblies for Functional Synthetic Cells and Artificial Tissues

Building a synthetic mechanosensitive signaling pathway in compartmentalized artificial cells

Protocells Featuring Membrane-Bound and Dynamic Membraneless Organelles